by Eric Christianson | Sep 11, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Clinical Pharmacy News and New Drug Updates, Medication and Disease State Clinical Pearls For Pharmacists
I’m a little bummed about my Minnesota Twins. Drug problems are everywhere and my team is not exempt. Apparently, hydrochlorothiazide is a drug of abuse in MLB’s drug testing policy. Mike Pineda, one of the Twins pitchers failed a drug test and was found...
by Eric Christianson | Aug 21, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
A 62-year-old male had a heart attack about 9 months ago. He was stented and placed on both aspirin 81 mg daily and clopidogrel 75 mg daily. He presents today to the emergency department and is diagnosed with a STEMI. His wife is wondering why the medications used to...
by Eric Christianson | Jun 26, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I recently did a podcast episode on heparin (which you can listen to below) and I did not mention hair loss as a potential adverse effect. In addition to heparin, it turns out there is data on other anticoagulants and this adverse effect as well. That begs the...
by Eric Christianson | Jun 23, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists, Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Alpha blockers are most frequently used in clinical practice to manage symptoms of BPH and probably less commonly used for hypertension. Here are a few relevant clinical practice pearls that are important to remember. Orthostasis/Syncope Alpha blockers are notorious...
by Eric Christianson | Jun 5, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
As a healthcare professional, when I hear the term heparin-induced thrombocytopenia (HIT), I get nervous. The classically taught heparin-induced thrombocytopenia (type 2) is very serious. HIT is something that needs to be closely watched for because consequences from...
by Eric Christianson | Mar 24, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Being a clinical pharmacist, you get asked a lot of questions about the differences amongst agents in the same class. The issue of differences between furosemide versus torsemide recently came up. I figured I would use the blog to cover some of those differences....
